title: DNA methylation directly silences genes with non-CpG island promoters and establishes a nucleosome occupied promoter.
abstract: Despite the fact that 45% of all human gene promoters do not contain CpG islands, the role of DNA methylation in control of non-CpG island promoters is controversial and its relevance in normal and pathological processes is poorly understood. Among the few studies which investigate the correlation between DNA methylation and expression of genes with non-CpG island promoters, the majority do not support the view that DNA methylation directly leads to transcription silencing of these genes. Our reporter assays and gene reactivation by 5-aza-2'-deoxycytidine, a DNA demethylating agent, show that DNA methylation occurring at CpG poor LAMB3 promoter and RUNX3 promoter 1(RUNX3 P1) can directly lead to transcriptional silencing in cells competent to express these genes in vitro. Using Nucleosome Occupancy Methylome- Sequencing, NOMe-Seq, a single-molecule, high-resolution nucleosome positioning assay, we demonstrate that active, but not inactive, non-CpG island promoters display a nucleosome-depleted region (NDR) immediately upstream of the transcription start site (TSS). Furthermore, using NOMe-Seq and clonal analysis, we show that in RUNX3 expressing 623 melanoma cells, RUNX3 P1 has two distinct chromatin configurations: one is unmethylated with an NDR upstream of the TSS; another is methylated and nucleosome occupied, indicating that RUNX3 P1 is monoallelically methylated. Together, these results demonstrate that the epigenetic signatures comprising DNA methylation, histone marks and nucleosome occupancy of non-CpG island promoters are almost identical to CpG island promoters, suggesting that aberrant methylation patterns of non-CpG island promoters may also contribute to tumorigenesis and should therefore be included in analyses of cancer epigenetics.
authors.affiliation: Department of Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California, Los Angeles, CA 90033, USA.
authors.forename: Han
authors.initials: H
authors.lastname: Han
authors.forename: Connie C
authors.initials: CC
authors.lastname: Cortez
authors.forename: Xiaojing
authors.initials: X
authors.lastname: Yang
authors.forename: Peter W
authors.initials: PW
authors.lastname: Nichols
authors.forename: Peter A
authors.initials: PA
authors.lastname: Jones
authors.forename: Gangning
authors.initials: G
authors.lastname: Liang
mesh_terms: D015815:Cell Adhesion Molecules / Q000235:genetics; D045744:Cell Line, Tumor; D002478:Cells, Cultured; D047369:Chromatin Immunoprecipitation; D050677:Core Binding Factor Alpha 3 Subunit / Q000235:genetics; D018899:CpG Islands / Q000235:genetics*; D019175:DNA Methylation / Q000187:drug effects / Q000235:genetics / Q000502:physiology*; D003841:Deoxycytidine / Q000494:pharmacology; D020868:Gene Silencing / Q000502:physiology*; D006801:Humans; D009707:Nucleosomes / Q000378:metabolism*; D011401:Promoter Regions, Genetic / Q000235:genetics*; D060888:Real-Time Polymerase Chain Reaction; D000097794:Kalinin
chemical_list: D015815:Cell Adhesion Molecules; D050677:Core Binding Factor Alpha 3 Subunit; D003841:Deoxycytidine; D009707:Nucleosomes; D000097794:Kalinin